August 2025
The global veterinary hematology analyzers market size is calculated at US$ 1.01 in 2024, grew to US$ 1.07 billion in 2025, and is projected to reach around US$ 1.72 billion by 2034. The market is expanding at a CAGR of 5.44% between 2025 and 2034.
There is a rise in the demand for the use of hematology analyzers due to growing pet health awareness. They are being used by various veterinary clinics to promote early diagnosis. AI is being integrated with them to enhance their workflow and accuracy. Their adoption rates in different regions are increasing due to growing pet routine checkups and increasing on-site diagnostics in clinics. The companies are collaborating for the development of advanced hematology analyzers as well as launching the same. Thus, these advancements are promoting the market growth.
Table | Scope |
Market Size in 2025 | USD 1.07 Billion |
Projected Market Size in 2034 | USD 1.72 Billion |
CAGR (2025 - 2034) | 5.44% |
Leading Region | North America Share 40% |
Market Segmentation | By Product Type, By Technology/Capability, By Animal Type/Species Application, By End User, By Region |
Top Key Players | IDEXX Laboratories, Zoetis, Heska Corporation, Sysmex, Mindray, SCIL Animal Care, Boule Diagnostics, HORIBA Medical, Erba Diagnostics, Siemens Healthineers, Abbott, Merck / MilliporeSigma / bioMérieux, Abaxis, Tosoh / Genrui / Mindray regional brands , Ortho Clinical Diagnostics, VetScan / Benchmark / small-OEMs, SediVue Diagnostics (Zoetis), Third-party consumables & cartridge suppliers, Distributor networks & service specialists, Emerging AI/slide-imaging companies |
The veterinary hematology analyzers market comprises instruments, reagents, consumables, and supporting services used to perform complete blood counts (CBC) and differential leukocyte analysis for animals. These analyzers automate hematology testing across companion animals (dogs, cats), equine, bovine, swine, avian, and exotic species, enabling faster diagnostics, improved clinical decision-making, and better patient throughput in veterinary clinics, diagnostic labs, and research facilities. Demand is driven by rising pet ownership, expanded veterinary care services, increasing preventive and specialty care, growth of veterinary reference labs, and adoption of point-of-care (POC) testing in clinics.
For instance,
Adopting AI in the veterinary services is transforming veterinary medicine, focusing on hematology. They are being used in the development of accurate hematology diagnostic tools. Point-of-care complete blood count (CBC) analyzers are also being developed to enhance the blood analysis capabilities with the help of AI. Moreover, different types of next-generation hematology analyzers are also being developed, which would provide faster and accurate blood analysis within a few minutes. AI also provides clinical decisions that help in enhancing animal care and satisfaction.
Rising Animal Health Awareness
The awareness about animal health among pet owners is increasing. This, in tu , is increasing the demand for veterinary hematology analyzers for the early detection of any infections or other diseases. They are also being used for the routine checkup for the analysis of the complete blood count. Moreover, they are also used for the management of disease, as they help in monitoring and adjusting the treatment prescribed, promoting the development of personalized medications. Thus, this drives the veterinary hematology analyzers market growth.
High Cost
The cost associated with the veterinary hematology analyzer prevents it from being adopted by various clinics. It also requires reagents, which are used continuously. Maintaining the workflow of the analyzer also requires regular calibrations and quality control. Thus, these add to the cost. Thus, all these factors affect the use and adoption rates of hematology analyzers.
The use of portable analyzers is increasing for providing on-site and real-time blood diagnostics. With their use, quick analysis is possible without any delays. This is increasing their use in emergency situations, as well as in remote areas for quick blood analysis. Their use for research purposes is also increasing, where they are being used by wildlife researchers or NGOs. At the same time, various innovations are also being conducted to develop solar-powered portable analyzers. Thus, this promotes the veterinary hematology analyzers market growth.
By product type, the benchtop/laboratory hematology analyzers segment held the dominating share of approximately 55% in the market in 2024, as they provided high accuracy. It offers the analysis of multiple samples. This increased their use in reference labs and larger clinics. This contributed to the market growth.
By product type, the compact/point-of-care (Poc)/in-clinic analyzers segment is expected to show the highest growth during the predicted time. They offer real-time diagnosis with faster results. This is increasing their use in clinics and emergency centers. Moreover, due to their easy use, their adoption is increasing.
By technology/capability type, the 3-part differential impedance analyzers segment led the market with approximately a 48% share in 2024, due to their robust veterinary uses. They offered a simple operation that increased their use in routine checkups. Additionally, their affordability increased their use.
By technology/capability type, the 5-part differential & flow cytometry-based instruments segment is expected to show the fastest growth rate during the predicted time. It provides high diagnostic accuracy and granularity. They are being used for the testing of various animals. Moreover, they are also being used in complex cases and research.
By animal type/species application type, the companion animals segment dominated the market in 2024, due to their regular veterinary visits. This increased the volume of tests and units placed in small-animal clinics. Moreover, the growing pet ownership and humanization are also increasing the use of hematology analyzers.
By animal type/species application type, the equine segment is expected to show the highest growth during the upcoming years, as there is a rise in equine sports. This, in tu , increases the use of hematology analyzers to monitor their health. Additionally, the growing awareness and on-site testing are also promoting its use. They are also being used within large-animal clinics and ambulatory services.
By end user, the veterinary clinics & small animal practices segment held the largest share of approximately 58% in the global market in 2024, because of increased companion animal visits. There was a rise in the regular visits, which increased the use of hematology analyzers. Similarly, the growing on-site testing also enhanced its use.
By end user, the academic & research institutions segment is expected to show the fastest growth rate during the upcoming years. The hematology analyzers are being used due to growing research. The increasing drug development and validation studies are also increasing its use. These studies are further supported by the gove ment funding.
North America dominated the veterinary hematology analyzers market share 40% in 2024. Due to the high pet healthcare spending, the use of veterinary hematology analyzers in North America increased. Moreover, the advanced veterinary infrastructure also enhanced their adoption. Thus, this contributed to the market growth.
The large volume of pets in the U.S. increased the demand for diagnostic tools, which increased the use of veterinary hematology analyzers. At the same time, the presence of dense clinic networks increased their use in the detection of diverse diseases. Moreover, the industries are also developing new software or handheld veterinary hematology analyzers.
The veterinary hematology analyzers were used in the routine checkups of the pets in Canada. The presence of well-equipped veterinary clinics and labs increased their adoption rates. The growing research and development in the institutes and industries are also increasing their use. Additionally, the 5-part differential analyzers are being used by these research centers.
Asia Pacific is expected to host the fastest-growing veterinary hematology analyzers market during the forecast period. Asia Pacific is experiencing a rise in pet ownership, which is increasing the demand for veterinary hematology analyzers. At the same time, growing urbanization and on-site diagnostics in clinics are also increasing the adoption of advanced technologies, promoting the use of hematology analyzers. The veterinary infrastructure is also improving, which is supported by the gove ment. Thus, this promotes the market growth.
The R&D of veterinary hematology analyzers focuses on the development of sophisticated, portable, and automated analyzers to enhance the multispecies compatibility, along with diagnostic capabilities.
Key Players: IDEXX Laboratories, Inc., Heska Corporation, Zoetis Inc., Sysmex Corporation, Abaxis Inc.
The safety, quality, and effectiveness of veterinary hematology analyzers, which must show high accuracy and reliability in compliance with the regulatory standards, are the criteria for receiving the clinical trial and regulatory approvals.
Key Players: IDEXX Laboratories, Zoetis Inc., Inc., Sysmex Corporation, Heska Corporation, Mindray Medical Inte ational Ltd.
The patient support and services for veterinary hematology analyzers include technical assistance, comprehensive training, and software updates to provide accurate diagnosis and optimal performance.
Key Players: Zoetis Inc., IDEXX Laboratories, Inc., Heska Corporation, Sysmex Corporation, and Boule Diagnostics.
In February 2024, after launching the IDEXX inVue Dx™ Cellular Analyzer, Guillermo Couto, DVM, DACVIM, stated that due to the inadequacies of slide-based samples, various practitioners, including himself, have struggled. But with the launch of IDEXX inVue Dx analyzer, they can now provide accurate diagnosis for our patients, with confidence, as this product provides slide-free workflow, which is backed by technology. Moreover, quick analysis of blood cell morphology is provided by IDEXX inVue Dx analyzer, by pairing it with ProCyte One® or ProCyte Dx® hematology analyzer.
By Product Type
By Technology/Capability
By End User
By Region
August 2025
August 2025
July 2025
July 2025